Infliximab News and Research

RSS
Infliximab is a monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied in the treatment and prevention of weight loss and loss of appetite in patients with advanced cancer. It belongs to the family of drugs called monoclonal antibodies.
Study: Early advanced therapy significantly improves Crohn's disease outcomes

Study: Early advanced therapy significantly improves Crohn's disease outcomes

Mood boosters reduce inflammation in IBD by 18%, study finds

Mood boosters reduce inflammation in IBD by 18%, study finds

AGA releases the first comprehensive evidence-based guideline on management of pouchitis

AGA releases the first comprehensive evidence-based guideline on management of pouchitis

Charting the future of IBD treatment: From immune modulators to microRNA therapies

Charting the future of IBD treatment: From immune modulators to microRNA therapies

Using TNF inhibitors during pregnancy not associated with worse fetal or obstetric outcomes

Using TNF inhibitors during pregnancy not associated with worse fetal or obstetric outcomes

Novel and emerging therapies offer new hope for patients with inflammatory bowel disease

Novel and emerging therapies offer new hope for patients with inflammatory bowel disease

Lack of direct comparisons prevents assessment of upadacitinib's benefit in Crohn's disease

Lack of direct comparisons prevents assessment of upadacitinib's benefit in Crohn's disease

Effectiveness of Lactobacillus in treating inflammatory bowel disease

Effectiveness of Lactobacillus in treating inflammatory bowel disease

How have inflammatory bowel disease treatments changed after the introduction of biologics?

How have inflammatory bowel disease treatments changed after the introduction of biologics?

Novel antibody could be safer and more effective than existing treatments for autoimmune diseases

Novel antibody could be safer and more effective than existing treatments for autoimmune diseases

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Clinical trial findings may be a game changer in the treatment of pediatric Crohn's disease

Clinical trial findings may be a game changer in the treatment of pediatric Crohn's disease

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

Case report on Nocardia pseudobrasiliensis and SARS-CoV-2 concomitant infection

Can the gut microbiota and metabolome explain variation in anti-SARS-CoV-2 vaccination responses in immunosuppressed IBD patients?

Can the gut microbiota and metabolome explain variation in anti-SARS-CoV-2 vaccination responses in immunosuppressed IBD patients?

Study shows how arthritis affects people's working lives

Study shows how arthritis affects people's working lives

Study establishes a feasible combination therapeutic strategy for ulcerative colitis

Study establishes a feasible combination therapeutic strategy for ulcerative colitis

New treatment guidelines published for anorectal abscess, anal fistula, and rectovaginal fistula

New treatment guidelines published for anorectal abscess, anal fistula, and rectovaginal fistula

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies